
Jointly sponsored by the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.
The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present the Viral Hepatitis Grand Rounds. This program is based on the ground-breaking CME activity "HIV Grand Rounds" which, in partnership with the Perelman School of Medicine at the University of Pennsylvania, is preparing for its fourth year running. These CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The "Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania" is delivered live via the Internet every second and fourth Wednesday of each month at 12:00pm Eastern Time and are available for on-demand viewing immediately following the live broadcast.
Presentations cover the most important and current topics in Hepatitis and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing Hepatitis clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These monthly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their Hepatitis patients.
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hepatitisgrandrounds for easy access.
The program has been designed for physicians, fellows, residents, medical students, nurses, nurse practitioners, physician assistants and allied health professionals in the medical specialties of Hepatology, Internal Medicine, Family Practice, Gastroenterology, as well as HIV/AIDS practitioners dealing with co-infection, other Infectious Disease specialists, Public Health professionals and other clinicians interested and involved in the care of patients with Hepatitis.
Commercial Support Acknowledgement:
These activities are supported by educational grants from Gilead Sciences Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., AbbVie Inc. and Vertex Pharmaceuticals Inc.
Learning Objectives for the Series:
![]() |
K. Rajender Reddy, MD
Professor of Medicine |
![]() |
Mark S. Sulkowski, MD
Professor of Medicine |
![]() |
John W. Ward, MD
Director, Division of Viral Hepatitis |
![]() |
Andrew J. Muir, MD, MHS
Associate Professor of Medicine |
![]() |
Marion G. Peters, MD
John V. Carbone MD Endowed Chair |
![]() |
Kenneth E. Sherman, MD, PhD
Gould Professor of Clinical Medicine |
![]() |
K. Rajender Reddy, MD
Professor of Medicine |
![]() |
Hashem B. El-Serag, MD, MPH
Dan L. Duncan Professor of Medicine |
Back to Top | |||
![]() |
Nezam H. Afdhal, MD
Professor of Medicine |
![]() |
Glenn J. Treisman, MD
Professor of Psychiatry and Behavioral Sciences |
![]() |
Alain H. Litwin, MD, MPH
Associate Professor of Clinical Psychiatry & Behavioral Sciences |
![]() |
Robert S. Brown Jr., MD MPH
Frank Cardile Professor of Medicine and Surgery |
![]() |
David E. Kaplan, MD MSc
Assistant Professor of Medicine at the Veteran's Administration Medical Center |
![]() |
Mark S. Sulkowski, MD
Professor of Medicine |
Back to Top | |||
![]() |
Gregory T. Everson, MD FACP
Professor of Medicine |
![]() |
Michael W. Fried, MD
Professor of Medicine |
![]() |
K. Rajender Reddy, MD
Professor of Medicine |
||
You will need Internet to participate in this activity.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.
The Perelman School of Medicine at the University of Pennsylvania designates each live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is policy at the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc. for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania (Rodman Campbell, Mila Kostic, Michael Schoen, PhD and Mindy Pollock Troy), our educational partner ViralEd, Inc. (Brian Boyle MD, Richard Gordon and Oliver Fultz), and the peer reviewer, Zalman Agus, MD, Associate Dean for Continuing Medical Education, have reported that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.
following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
John W. Ward MD | Kenneth E. Sherman MD PhD | Hashem B. El-Serag, MD MPH | David E. Kaplan, MD MSc |
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
Presenters Name |
Commercial Supporter |
Relationship |
K. Rajender Reddy, MD |
BMS; Gilead; Vertex; Tibotec/Janssen; Merck; Genentech-Roche; Anadys; Ikaria; Hyperion |
Contracted Research |
Merck; Genentech-Roche; Gilead; Tibotec-Jannsen; Vertex |
Consulting Fees |
Mark S. Sulkowski, MD |
AbbVie; BIPI; BMS; Gilead; Idenix; Janssen; Merck; Vertex |
Honorarium - Scientific Advisor |
AbbVie; BIPI; BMS; Gilead; Janssen; Merck; Vertex |
Research |
Andrew J. Muir MD MHS |
Abbott, Achillion, BMS, Gilead, GSK, GlobeImmune, Medtronic, Merck, Pfizer, Roche, Salix, Scynexis, Vertex Pharmaceuticals |
Grant / Research Funding |
Achillion, BMS, Merck, Profectus BioSciences Inc., Scynexis, Vertex Pharmaceuticals |
Consulting or Other Services (including CME) |
Marian G. Peters MD |
Biotron; Clinical Care Options; International Antiviral Society (IAS-USA);Theravance 2012 |
Advisory Board Member |
International Antiviral Society (IAS-USA); Roche |
Speaker/honorarium |
|
Genentech Research and Development (Subsidiary of Roche) |
Spouse is an employee |
K. Rajender Reddy MD |
Merck, Genentech-Roche, Vertex, Gilead, Janssen, BMS |
Ad Hoc Advisory Board |
Merck, BMS, Gilead, Vertex, Janssen, Abbott |
Clinical Research - Support to the Institution |
Nezam H. Afdhal, MD |
Merck, GSK, Vertex, Gilead, Abbott, BMS |
Research Support |
Merck, Gilead, Echosens, GSK, Vertex, Novartis, Boehringer Ingelheim, Ligan, Springbank, Medgenics, Kadmon |
Consultant / Advisory Board Member |
|
Springbank, Medgenics | Stock Options |
Alain H. Litwin, MD MPH | Kadmon Pharmaceutical |
Honorarium; Monograph Adherence |
Janssen Pharmaceutical |
Honorarium; Advisory |
Robert S. Brown Jr., MD MPH | Gilead, Genentech | Consulting & Teaching |
Mark S. Sulkowski, MD |
AbbVie; BIPI; BMS; Gilead; Idenix; Janssen; Merck; Vertex |
Honorarium - Scientific Advisor |
AbbVie; BIPI; BMS; Gilead; Janssen; Merck; Vertex |
Research |
Gregory T. Everson, MD | Roche/Genentech, Vertex, GlobeImmune, BMS Abbott Eisai, HGS/novartis, Pfizer, Gilead, Janssen/Tibotec | Advisory Boards |
Roche-Genentech, HGS/Novartis, BMS, Three Rivers, Vertex, Abbott | Consulting | |
Merck, Centocor | DSMB | |
Source, HepQuant LLC | Stock/Ownership | |
HepQuant LLC | Management | |
Roiche/Genentech, Schering, Vertex, GlobeImmune, Gilead, HGS/Novartis, BMS, Pfizer, Source, Eisai, GSK, Pharmassett, Ortho Biotech, Janssen/Tibotec, Medtronic | Research Grants |
Michael W. Fried, MD | Genentech/Roche, Merck, Vertex, Tibotec/Janssen, Gilead, BMS, Abbott |
Grants/Research Support |
Genentech/Roche, Tibotec,/Janssen, Vertex, Merck, Glaxo, Novartix, Abbott, Gilead, BMS |
Consultant | |
NIH | Research Grants |
K. Rajender Reddy, MD |
BMS; Gilead; Vertex; Tibotec/Janssen; Merck; Genentech-Roche; Anadys; Ikaria; Hyperion |
Contracted Research |
Merck; Genentech-Roche; Gilead; Tibotec-Jannsen; Vertex |
Consulting Fees |
Discussion of Investigational and/or Off-label Use of Commercial Products and Devices:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
You may contact Richard Gordon by phone at 1-856-506-5790 or by email at Rgordon@viraled.com for additional assistance.
For CME questions please contact the Perelman School of Medicine at the University of Pennsylvania Office of CME: penncme@mail.med.upenn.edu.
We look forward to bringing the highest quality, outcomes driven CME directly to you.